The 3 most recent market catalysts affecting $SCNI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Neutral
Impact 55
Scinai Files Prospectus For Resale Of Up To 2,706,450 ADS By YA II PN
Scinai Technologies has filed a prospectus for the resale of up to 2,706,450 ADSs by YA II PN, Ltd. This filing is a standard procedure required when a large investor, often a fina…
Aug 24, 2026
Corporate Catalyst
Bullish
Impact 75
Scinai Immunotherapeutics H1 Net Income $1.6M Vs Loss $4.1M Prior Year; Revenues $949K Up From $773K YoY; Continues To Pursue ~$5M In CDMO Revenues For 2026
Scinai Immunotherapeutics reported a net income of $1.6 million for the first half of 2026, a notable improvement from a $4.1 million loss in the prior year. However, this positive…
Aug 19, 2026
Corporate Catalyst
Bullish
Impact 75
Scinai Immunotherapeutics shares are trading higher after the company announced a 1‑for‑10 ADS reverse split effective August 21.
A reverse stock split, while often seen as a negative signal, can sometimes lead to a short-term positive reaction as the share price increases, potentially making the stock more a…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.